Novartis Investigator Site

Evansville, Indiana 47713

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Ankylosing Spondylitis Clinical Trial
Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Evansville, IN
Click here to add this to my saved trials